Ulrich Moebius

Chief Development Officer @Sotio Biotech

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2025 — Present

Chief Development Officer @Sotio Biotech

View department →

EDUCATION

1987

University Mainz

Dipl. Biol., PhD, Biology, Immunology

1997

University Heidelberg

Habilitation, Medicine, Immunology

SKILLS

Preclinical DevelopmentOnkologieClinical TrialsBiowissenschaftenLife SciencesPharmaforschungEarly Clinical DevelopmentForschung Und EntwicklungImpfstoffeBiotechnologyOncologyImmunologieKlinische EntwicklungPharma Project ManagementBiotechnologieClinical DevelopmentProject EvaluationBiopharmazeutikaPharmakologiePharmaindustrieImmunologyArzneimittelentwicklung

ABOUT ULRICH MOEBIUS

Life scientist, PhD in immunology, 10 years immunology / immune-oncology research at Harvard University, Dana Faber Cancer Institute, and German Cancer Research Center. 18 years drug development in R&D leadership positions at Pieris Inc, MorphoSys AG and MediGene AG. Management of multi-disciplinary drug development projects from research stage to clinical phase II studies including nonclinical, CMC, regulatory and clinical activities.Experience with biologics (antibodies, scaffold proteins, recombinant virus), herbal and small molecule drugs.Development experience in oncology and autoimmunity indications. Contribution to company strategy and financing, execution of road shows and investor discussions.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ulrich Moebius — Chief Development Officer at Sotio Biotech in Munich, DE | Unifers